AI-assisted, human-published
03/23/2026 /Funding Events
Oryon Cell Therapies Secures $21M Funding for Parkinson's Disease Research
Oryon Cell Therapies emerges from stealth with a $21 million tranche for its Series A financing, focusing on developing neuron replacement therapies for Parkinson's disease.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com